The bite of the lone star tick can cause alpha-gal syndrome, an allergic condition to red meat and other mammalian food products. UT Southwestern answers common questions about the condition.
The FDA has approved pembrolizumab immunotherapy, the first treatment to lower kidney cancer recurrence risk after surgery. UT Southwestern helps patients explore its benefits and risks.
The Associate Vice President of Commercialization and Business Development at UT Southwestern shares her experience battling the novel coronavirus and then donating her plasma in hopes of helping others.
Immunotherapy has dramatically improved melanoma survival rates. In this week's MedBlog, Terry Hart tells his story of surviving advanced melanoma through immunotherapy.
The world’s scientists and physicians, including many of at UT Southwestern, have rallied together to conduct clinical trials and research around COVID-19. UT Southwestern shares recent discoveries and offers a glimpse at what a vaccine might look like.
Melanoma rates are increasing in the U.S., even as incidences of other cancers are declining. However, treatment advances in the last decade have tripled survival rates for advanced melanoma.
More than 90 percent of patients who believe they are allergic to penicillin actually aren’t. This is a serious concern, particularly during pregnancy. In this week’s Your Pregnancy Matters blog, UT Southwestern discusses penicillin allergy testing and antibiotic safety.
